Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has been updated to reflect new dates and a revision number, indicating a version change from v2.15.0 to v2.15.2.SummaryDifference1%
- Check46 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a clinical trial for metastatic uveal melanoma and the addition of new collaborators and a revision number. The principal investigator's name has also been updated.SummaryDifference31%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 12, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.3%
- Check75 days agoChange DetectedThe webpage has been updated with new dates for events, specifically changing from 2024 to 2025, indicating a shift in scheduling. Additionally, the status of recruitment has been clarified to 'Completed'.SummaryDifference1%
Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.